Smad4 is a key transcription factor in the TGF-β pathway, and malignant progression in prostate, colon and pancreatic carcinomas is associated with Smad4 loss (Demagny & De Robertis, 2016). The gene discussed is TGFB1; the disease is exocrine pancreatic carcinoma.